← Back to Search

Procedure

Radiofrequency Ablation for Thyroid Nodules

N/A

Recruiting

Led By Daniel Kuriloff, MD

Research Sponsored by Northwell Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects who have a benign, symptomatic thyroid nodule

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is studying a minimally-invasive procedure to treat benign thyroid nodules without the risks of surgery. It's looking to see if it's an effective and safe option for LatinX patients.

Who is the study for?

This trial is for Latinx individuals over 18 with benign, symptomatic thyroid nodules who can consent to treatment and follow study procedures. They must have a well-defined nodule on ultrasound. It's not for those on blood thinners, with acute illness, high blood pressure, cardiac devices, or pregnant/breastfeeding women.Check my eligibility

What is being tested?

The Mygen V-1000 RF system is being tested as a minimally-invasive alternative to surgery for treating thyroid nodules in Latinx patients. The goal is to see if radiofrequency ablation (RFA) can safely resolve issues without the risks associated with traditional surgery.See study design

What are the potential side effects?

While specific side effects are not listed here, RFA may generally include discomfort at the site of treatment, swelling, bruising or minor bleeding. Since it avoids surgery risks like anesthesia complications and significant bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a non-cancerous thyroid lump that causes symptoms.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with treatment-related changes in thyroid nodule volumes

Trial Design

1Treatment groups

Experimental Treatment

Group I: Mygen V-1000 RF systemExperimental Treatment1 Intervention

The Mygen V-1000, a microprocessor-based generator of RF Medical Co., Ltd., provides up to 140 watts of radio-frequency (RF) energy to be used for coagulation & ablation of vessel, tissue & bone

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor

460 Previous Clinical Trials

470,999 Total Patients Enrolled

Daniel Kuriloff, MDPrincipal InvestigatorNorthwell Health

Media Library

Mygen V-1000 RF system (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05903196 — N/A

Thyroid Nodule Research Study Groups: Mygen V-1000 RF system

Thyroid Nodule Clinical Trial 2023: Mygen V-1000 RF system Highlights & Side Effects. Trial Name: NCT05903196 — N/A

Mygen V-1000 RF system (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05903196 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are the criteria for participation accommodating to my condition?

"Eligibility criteria for this trial require that potential participants have a thyroid nodule and be between 18-90 years of age. A total of 44 patients are required to complete the study."

Answered by AI

Is there still an opportunity to participate in this experiment?

"Affirmative. The data on clinicaltrials.gov indicates that this trial, first posted in August of 2023 and recently modified in June of the same year, is currently recruiting participants. They are searching for 44 individuals to participate at 1 specific location."

Answered by AI

Is the cut-off age for eligibility in this clinical trial thirty or above?

"Individuals between 18 and 90 years of age are eligible to apply for this clinical trial. There is a separate study enrolling patients under the age of 18, as well as another one accommodating those over 65."

Answered by AI

What is the upper limit of participants engaging in this clinical experiment?

"That is accurate. According to the information accessible on clinicaltrials.gov, this medical trial was launched on August 22nd 2023 and recently modified on June 13th 2023. 44 participants from a single site are needed for enrollment in this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Radiofrequency Ablation Study in LatinX Patients

Daniel Kuriloff 2024. "Radiofrequency Ablation Study in LatinX Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05903196.